- Companies
- proteanTecs
proteanTecs Revenue, Valuation, Funding & Investors
proteanTecs is valued at $600M as of September 2025, a 10.0x multiple on its last reported $60M revenue.
Last proteanTecs valuation
$600M
Series D · Sep 2025
Last proteanTecs funding round
Undisclosed stage
Amount undisclosed · Mar 2026
proteanTecs revenue
$60M
Series D · Sep 2025
Key investors in proteanTecs
Intel Capital
Koch Disruptive Technologies
Addition
Zeev Ventures
Redline Capital
Porsche SE
About proteanTecs
proteanTecs is an Israel-headquartered semiconductor firm offering chip telemetry platforms for health monitoring. Its Agent technology embeds sensors in SoCs to track aging, performance degradation, and defects from design through field deployment. The company's software applies machine learning to telemetry data for anomaly detection and yield improvement, serving hyperscalers and automotive chipmakers. proteanTecs partners with TSMC and Intel foundries to integrate its solutions into 5nm and advanced nodes, enabling traceability across the electronics supply chain.
Founded
2017
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Licensing, Subscription
Revenue
$60M (Sep 2025)
Valuation
$600M (Sep 2025)
proteanTecs Valuation
proteanTecs is currently valued at $600M, based on its Series D in September 2025.
The $51M round was led by IAG Capital Partners, with participation from Porsche SE, Zeev Ventures, ARM, Avigdor Willenz, Addition and 5 other investors.
proteanTecs' valuation has grown 1.1x from $558M at its Series C in September 2021 to $600M in September 2025, across 3 priced rounds.
proteanTecs valuation by funding round
Revenue multiple| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Sep 2025 | Series D | $600M | 10.0x |
| May 2022 | Series C | $184M | 10.2x |
| Sep 2021 | Series C | $558M | - |
proteanTecs Revenue
proteanTecs' latest recorded revenue is $60M, as of its Series D in September 2025. At a $600M valuation, that implies a 10.0x revenue multiple.
Revenue grew from $18M in May 2022 to $60M in September 2025, while the revenue multiple moved from 10.2x to 10.0x.
proteanTecs revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Sep 2025 | $60M | $600M | 10.0x | Series D |
| May 2022 | $18M | $184M | 10.2x | Series C |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
proteanTecs Funding History
proteanTecs has raised a total of $236M across 7 funding rounds.
proteanTecs' first fundraising round was a $10M Series A in May 2017. The most recent completed round was a undisclosed-stage round in March 2026.
proteanTecs funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Mar 2026 | Undisclosed stage | TGVP (lead) | - | - | - |
| Sep 2025 | Series D | IAG Capital Partners (lead); Porsche SE; Zeev Ventures; ARM; Avigdor Willenz; Addition; Samsung Catalyst Fund; Koch Disruptive Technologies; Siemens; MediaTek Ventures; Intel Capital | $51M | $600M | proteanTecs, an Israeli startup founded in 2017 by Mellanox veterans including CEO Shai Cohen, develops telemetry-based deep data solutions for electronics health and performance monitoring. The company's technology provides predictive lifecycle monitoring to optimize power, performance, resilience, and safety in complex electronic systems, serving cloud hyperscalers, leading semiconductor firms like TSMC, Intel, Global Foundries, Microsoft, and Annapurna Labs, and expanding into automotive, consumer electronics, and telecom. With over 200 employees and offices in Israel, the US, India, and Taiwan, proteanTecs improves performance in millions of GPUs for AI training/inference and server processors in data centers. In September 2025, proteanTecs closed a $51 million Series D funding round led by IAG Capital Partners, with new investors Samsung Catalyst Fund, Arm, and Siemens, plus existing backers Addition, Zeev Ventures, Avigdor Willenz Group, MediaTek Ventures (noted as Innovation Fund in some reports), Intel Capital, Porsche Automobil Holding SE, and Koch Disruptive Technologies. This round brings total funding raised to over $250 million. The capital supports scale-up in key markets, new product development, deeper electronics value chain integration, global expansion, and accelerated rollout with major customers. Near the round, annual sales were estimated at over $60 million, yielding a valuation of over $600 million for the ~$50-51M raise at a 10x revenue multiple, described as relatively low and comparable to chip industry peers like AMD (6x) and TSMC (7x). Prior valuations fluctuated from $558 million in 2021 to $184 million in 2022. IAG Capital highlighted proteanTecs' strong market pull, high-value model, and complementarity to next-gen silicon and advanced computing investments. |
| May 2022 | Series C | Addition (lead) | $45M | $184M | proteanTecs, a Haifa-based Israeli company founded in 2017 by former Mellanox executives, develops deep data analytics and telemetry-based solutions for monitoring the health, performance, power, and reliability of advanced electronics and semiconductors, serving cloud hyperscalers, chipmakers like Microsoft, Annapurna Labs, TSMC, Intel, Global Foundries, and expanding into automotive, consumer electronics, and telecom. The company, with over 200 employees and offices in the US, India, and Taiwan, had signed major partnerships and was raising funds amid market pressures. This followed a $51M Series D in September 2021 at $300M valuation led by Mitsui & Co. and Koch Disruptive Technologies. Total funding by mid-2022 reached around $250M including prior rounds from investors like Intel Capital, Porsche Automobil Holding, and others; Addition participated in later rounds as well. At the time of the 2022 round, annual sales exceeded $60 million, yielding a funding multiple of around 10x sales, comparable to peers like AMD (6x), TSMC (7x), and Nvidia (20x). The funds supported product acceleration, team expansion, global scaling, and deeper customer integrations amid rising SoC complexity. Subsequent Series D extensions in late 2022 or later added $51M from IAG Capital Partners, Arm, Samsung Catalyst Fund, Siemens, and existing backers including Addition. |
| Sep 2021 | Series C | Koch Disruptive Technologies (lead); Porsche SE; Champion Motors; Advantest; MediaTek Ventures | $50M | $558M | proteanTecs develops deep data solutions for electronics health and performance monitoring, enabling digital systems to report their own health via chip telemetry analytics, improving production quality and fleet management across datacenter, cloud, AI, communications, and automotive sectors. The company, founded in 2017 by executives from Mellanox (acquired by Nvidia), serves major electronics vendors with silicon-proven solutions in advanced process technologies. On September 23, 2021, proteanTecs announced a $50 million extension to its prior growth equity round, led by Koch Disruptive Technologies (KDT), with participation from strategic investors MediaTek, Advantest, Porsche Automobil Holding SE (Porsche SE), Champion Motors (Allied Group subsidiary), and existing investors, bringing total funding to $150 million. The funds aimed to accelerate market adoption, expand globally, enhance products, and scale operations amid growing demand from chip vendors, system integrators, and service providers. Subsequent rounds included a $51 million Series D in 2025 led by Mitsui & Co. and IAG Capital Partners with Arm, Samsung, and Siemens, pushing total funding over $250 million, and a down round in May 2022 at $184 million valuation. |
| Aug 2020 | Series C | Koch Disruptive Technologies (lead); Atreides Management; Redline Capital; Valor Equity Partners; Intel Capital | $45M | - | proteanTecs, founded in 2017 and headquartered in Haifa, Israel, develops Deep Data solutions for electronics health and performance monitoring, enabling digital systems to report on their own status throughout the lifecycle using chip-embedded agents and machine learning analytics. This technology addresses challenges in advanced electronics by providing visibility into chip performance, improving production quality, optimizing fleet management, and alerting on faults before failures. The company serves major vendors in datacenter, cloud, AI, communications, automotive, and other sectors, with solutions silicon-proven at high volumes in single-digit process technologies. On August 27, 2020, proteanTecs closed a $45 million growth equity round led by Koch Disruptive Technologies (KDT), with participation from Valor Equity Partners, Atreides Management, Intel Capital, Redline Capital, and existing investors including Viola Ventures and WRVI Capital. The funding aims to accelerate market penetration, scale business operations, enhance product offerings, expand global footprint, and meet growing customer demand amid increasing design complexity in electronics. CEO Shai Cohen highlighted leveraging existing commercial traction to provide greater value to chip vendors, system integrators, and service providers. Investors praised proteanTecs for spearheading a new category in Deep Data, combining disciplines to empower self-monitoring electronics and reinvent ecosystem approaches to performance tracking. Eli Groner of KDT noted the need for new tracking methods as reliance on electronics grows, while Zvika Orron of Viola Ventures affirmed the company's visionary execution and market need. Lip-Bu Tan of WRVI Capital commended the team's progress toward certainty and predictability in the industry. This round brought cumulative funding to roughly $95 million, positioning proteanTecs for further growth in high-demand sectors. |
| Apr 2019 | Series B | Zeev Ventures; Avigdor Willenz; Viola Ventures; Redline Capital; Mitsubishi UFJ Capital; ITI Venture Capital Partners; Celesta Capital; Intel Capital | $35M | - | proteanTecs, founded in 2017 in Haifa, Israel by executives including former Mellanox founders Shai Cohen (CEO), Evelyn Landman (CTO), Roni Ashuri (COO), Yahel David, Eyal Fayneh, and Yuval Bonen, develops deep data solutions for electronics health and performance monitoring. The company's telemetry-based platform embeds agents in chips to provide predictive lifecycle monitoring, optimizing power, performance, resilience, and safety using machine learning and data analytics for quality control, reliability tracking, and fault prediction across chip vendors, system vendors, and digital service providers. On April 1, 2019, proteanTecs completed a $35 million Series B funding round, led by investors including Avigdor Willenz, Intel Capital, ITI Venture Capital Partners, Mitsubishi UFJ Capital, Redline Capital Management, Viola Ventures, WRVI Capital, and Zeev Ventures. This brought total funding to nearly $50 million, with Viola Ventures having led the prior round. The capital was earmarked to accelerate development and adoption of its technology, which was already in use by diversified customers in semiconductors. The company has since raised substantially more, including a $45 million growth equity extension from Addition in May 2022 (totaling nearly $200 million), and a $51 million Series D in 2025 led by IAG Capital Partners with participants like Arm, Samsung Catalyst Fund, Siemens, Intel Capital, Zeev Ventures, Avigdor Willenz Group, MediaTek, Porsche SE, and Koch Disruptive Technologies (totaling over $250 million). Funds supported global expansion, product development, team growth to over 200 employees, and integrations in datacenters, automotive, cloud, telecom, and hyperscalers. |
| May 2017 | Series A | - | $10M | - | - |
Who has invested in proteanTecs?
21 investors have backed proteanTecs across its funding rounds, including Intel Capital, Koch Disruptive Technologies, Addition, Zeev Ventures, Redline Capital and Porsche SE.
Lead investors include TGVP, IAG Capital Partners, Addition and Koch Disruptive Technologies.
proteanTecs Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Lead | Aug 2020 | ||
| 3 | Participant | Apr 2019 | ||
| 2 | Participant | Sep 2021 | ||
| 2 | Participant | Apr 2019 | ||
| -- | 2 | Participant | Apr 2019 | |
| 2 | Lead | May 2022 | ||
| 2 | Participant | Apr 2019 | ||
| 2 | Participant | Sep 2021 | ||
| 1 | Participant | Sep 2025 | ||
| 1 | Participant | Aug 2020 | ||
| 1 | Lead | Sep 2025 | ||
| 1 | Participant | Apr 2019 | ||
| 1 | Participant | Sep 2025 | ||
This data is available for Pro users. Sign up to see all 21 proteanTecs investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialproteanTecs Competitors
proteanTecs competitors include listed companies like Shenzhen Sunwin and Intelligo Technology, and private ones like Tractian, Autosys Industrial Solutions Private Limited, Auradine and Tive.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $720M | - | ||
| Private | - | - | $651M | - | ||
| Publicly listed | $20M | ($147M) | $687M | - | ||
| Private | - | - | $500M | - | ||
| Private | $25M | - | $500M | - | ||
| Publicly listed | $50M | $20M | $522M | 8.4x |
proteanTecs Public Comps
proteanTecs is still privately-owned, but its public comps include Yuil Robotics, Hanwang Technology Co, Unisound Ai Technology, M31 Technology, Baida Group Co, Seco, PKSHA Technology, Jiangxi Tianli Technology, Qualitau and Weebit Nano.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $27M | ($16M) | 21.9x | - | (35.8x) | - | |||
| $282M | ($14M) | 2.2x | - | (44.4x) | - | |||
| $181M | ($22M) | 3.0x | 2.1x | (24.5x) | (36.1x) | |||
| $56M | $5M | 10.2x | 9.5x | 120.6x | 81.6x | |||
| $31M | $9M | 13.6x | - | 45.2x | - | |||
| $229M | $32M | 3.2x | 3.0x | 22.4x | 14.6x | |||
| $140M | $47M | 4.1x | 2.4x | 12.2x | 10.7x | |||
| $73M | $69K | 7.2x | - | 7603.1x | - | |||
This data is available for Pro users. Sign up to see all proteanTecs competitors and their valuation data. Start Free Trial | ||||||||
Common questions about proteanTecs
| When was proteanTecs founded? | proteanTecs was founded in 2017. |
| Where is proteanTecs headquartered? | proteanTecs is headquartered in Haifa, Israel. |
| Is proteanTecs publicly listed? | No, proteanTecs is a private, VC-backed company. |
| What is proteanTecs' valuation? | proteanTecs was last valued at $600M in its Series D in September 2025. |
| How much funding has proteanTecs raised? | proteanTecs has raised $236M across 7 funding rounds. |
| What was proteanTecs' last funding round? | proteanTecs' last funding round was a undisclosed-stage round in March 2026, led by TGVP. |
| Who are proteanTecs' investors? | proteanTecs' investors include Koch Disruptive Technologies, Intel Capital, Porsche SE, Zeev Ventures, Avigdor Willenz, Addition, Redline Capital, MediaTek Ventures, ARM, Atreides Management and 11 others. |
| What is proteanTecs' revenue? | proteanTecs' latest recorded revenue is $60M (September 2025). |
| What is proteanTecs' revenue multiple? | proteanTecs' latest valuation implies a 10.0x revenue multiple ($600M valuation on $60M of revenue). |
| Which companies are comparable to proteanTecs? | Companies comparable to proteanTecs include Tractian, Autosys Industrial Solutions Private Limited, Shenzhen Sunwin, Auradine, Tive and Intelligo Technology. |
See companies similar to proteanTecs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




